DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Innovision Limited — Awarding of order(s)/contract(s)

NSE 1d ago·29 Aug 2026, 10:50 am

INNOVISION NSE

Innovision Limited has announced the receipt of new orders or contracts, marking a significant milestone for the company. This development signals a potential increase in business activity and revenue streams for the firm.

For investors, this news is generally viewed positively as it indicates growing demand for the company's products or services. It can boost confidence in the company's operational strength and future growth prospects.

Investors should monitor the total value of these new orders and the timeline for execution. Keeping an eye on the company's upcoming financial reports will provide further clarity on how these new contracts impact the bottom line.